Genetic diversity of mitomycin C-hypersensitive Chinese hamster cell mutants: a new complementation group with chromosomal instability

Somat Cell Mol Genet. 1993 Sep;19(5):431-7. doi: 10.1007/BF01233248.

Abstract

A Chinese hamster cell mutant (V-C8) isolated previously, which is approximately 100 fold more sensitive to mitomycin C (MMC) than its parental wild-type V79 cells (judged by D10 values), was further characterized. V-C8 cells exhibit an increased sensitivity towards other cross-linking agents, such as cis-DDP (approximately 40-fold), DEB (approximately 30-fold), and also to adriamycin (approximately 5-fold), and the monofunctional alkylating agents: MMS (approximately 5-fold) and EMS (approximately 6-fold). V-C8 cells show a higher level induction of chromosomal aberrations by cross-linking agents (MMC, cis-DDP, and DEB) and an increased level of spontaneous chromosomal aberrations in comparison to the wild-type V79 cells. To determine whether the V-C8 mutant represents a new complementation group among Chinese hamster cell mutants that also display the extreme sensitivity to MMC, V-C8 cells were fused with irs1, irs1SF, UV20, UV41, and V-H4 cells. In all cases, the derived hybrids regained the MMC sensitivity similar to wild-type cells, indicating that the V-C8 mutant belongs to a new sixth complementation group.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CHO Cells
  • Cell Survival
  • Chromosome Aberrations / genetics*
  • Cisplatin / pharmacology
  • Cricetinae
  • DNA Damage
  • Dose-Response Relationship, Drug
  • Doxorubicin / pharmacology
  • Epoxy Compounds / pharmacology
  • Genetic Complementation Test
  • Genetic Variation
  • Mitomycin / pharmacology*
  • Mutation / genetics*

Substances

  • Epoxy Compounds
  • Mitomycin
  • diepoxybutane
  • Doxorubicin
  • Cisplatin